Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts
The utility of plasma amyloid beta (Aβ) and tau levels for the clinical diagnosis of Alzheimer’s disease (AD) dementia has been controversial. The main objective of this study was to compare Aβ42 and tau levels measured by the ultra-sensitive immunomagnetic reduction (IMR) assays in plasma samples c...
Main Authors: | Lih-Fen Lue, Marwan N. Sabbagh, Ming-Jang Chiu, Naomi Jing, Noelle L. Snyder, Christopher Schmitz, Andre Guerra, Christine M. Belden, Ta-Fu Chen, Che-Chuan Yang, Shieh-Yueh Yang, Douglas G. Walker, Kewei Chen, Eric M. Reiman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-07-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fnagi.2017.00226/full |
Similar Items
-
Long-Term Storage Effects on Stability of Aβ1–40, Aβ1–42, and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays
by: Ming-Jang Chiu, et al.
Published: (2019-02-01) -
Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology
by: Lih-Fen Lue, et al.
Published: (2019-12-01) -
Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects
by: Lih-Fen Lue, et al.
Published: (2019-09-01) -
Corrigendum: Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects
by: Lih-Fen Lue, et al.
Published: (2019-11-01) -
Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer’s Disease?
by: Lih-Fen Lue, et al.
Published: (2012-01-01)